Records containing: Primary Immune Deficiency
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-08-06Prospective, Open-label, Single-arm, Multicentre Phase 3 Study to Evaluate the Pharmacokinetics, Efficacy, Tolerability, and Safety of Subcutaneous Human Immunoglobulin (Newnorm) in Patients With Primary Immunodeficiency Diseases
-
CLINICAL_TRIALS study record update · 2026-07-16Prospective, Open-label, Single-arm, Multicentre Phase 3 Study to Evaluate the Pharmacokinetics, Efficacy, Tolerability, and Safety of Subcutaneous Human Immunoglobulin (Newnorm) in Patients With Primary Immunodeficiency Diseases
-
CLINICAL_TRIALS study record update · 2026-06-05Prospective, Open-label, Single-arm, Multicentre Phase 3 Study to Evaluate the Pharmacokinetics, Efficacy, Tolerability, and Safety of Subcutaneous Human Immunoglobulin (Newnorm) in Patients With Primary Immunodeficiency Diseases
-
CLINICAL_TRIALS study record update · 2026-04-14Screening Protocol for Genetic Diseases of Lymphocyte Homeostasis and Programmed Cell Death
-
CLINICAL_TRIALS study record update · 2026-03-09Primitive Immunodeficiency and Pregnancy
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-02-17Biologics And Clinical Immunology Cohort at Sinai
-
CLINICAL_TRIALS study record update · 2025-10-03Prospective, Open-label, Single-arm, Multicentre Phase 3 Study to Evaluate the Pharmacokinetics, Efficacy, Tolerability, and Safety of Subcutaneous Human Immunoglobulin (Newnorm) in Patients With Primary Immunodeficiency Diseases
-
CLINICAL_TRIALS study record update · 2025-08-21Characterizing the Upper Airway Manifestations in Primary Ciliary Dyskinesia and Primary Immunodeficiencies
-
CLINICAL_TRIALS study record update · 2025-08-21Defining the Genetic Etiology of Suppurative Lung Disease in Children and Adults
-
CLINICAL_TRIALS study record update · 2025-07-25An Open-Label, Single-Arm, Historically Controlled, Prospective, Multi-Center Phase III Study to Evaluate the Pharmacokinetics and Safety of Immune Globulin Intravenous (Human) GC5107 in Pediatric Subjects With Primary Humoral Immunodeficiency
-
CLINICAL_TRIALS study record update · 2025-06-03Vaccine-induced SARS-CoV-2-specific T Cell Responses in Patients With Primary Immune Deficiency Disease
-
CLINICAL_TRIALS study record update · 2025-03-05Worldwide COVID-19 in Children and Adult Patients With Primary ImmunoDeficiencies (PID) Survey
-
CLINICAL_TRIALS study record update · 2024-02-28Evaluation of Adult Patients With Immunodeficiency Within the Scope of the International Classification of Functionality, Ability and Health
-
CLINICAL_TRIALS study record update · 2023-07-06Evaluating Bronchodilator Response in Patients With Bronchiectasis
-
CLINICAL_TRIALS study record update · 2022-09-16An Open Label, Multicenter Study to Evaluate the Pharmacokinetics, Efficacy and Safety of ASCENIV™ (IGIV) in Pediatric Subjects With Primary Immunodeficiency Diseases (PIDD)
-
CLINICAL_TRIALS study record update · 2022-07-27A Prospective Monocentric Study to Assess the Concordance of Lung MRI Compared to Chest CT Scan to Assess the Extent and Severity of Bronchial and Parenchymal Pulmonary Lesions in Adult Patients With Primary Immune Deficiency (PID): IRM vs SCANNER
-
CLINICAL_TRIALS study record update · 2021-10-15Evaluation of Immune Response to Vaccines in Primary Immune Disorders
-
CLINICAL_TRIALS study record update · 2019-10-25Phase I Study of Transfer of Effector Memory T Cells (Tem) Following Allogeneic Stem Cell Transplantation
-
CLINICAL_TRIALS study record update · 2018-02-26Study of Immune Deficiency Patients Treated With Subcutaneous Immunoglobulin (IgPro20, Hizentra®) on Weekly and Biweekly Schedules
-
CLINICAL_TRIALS study record update · 2016-08-16Determinants of Health Status and Quality of Life in Patients With Primary Immunodeficiencies Inhereted Diagnosed During Childhood
-
CLINICAL_TRIALS study record update · 2014-12-02A Multicenter Study of Long-Term Clinical Outcomes of Immune Globulin Subcutaneous (Human) (SCIG) IgPro20 in Subjects With Primary Immunodeficiency
-
CLINICAL_TRIALS study record update · 2013-06-19An Open-Label Study of Ig NextGen 16% Administered by Subcutaneous Infusion in Patients With Primary Immunodeficiency (PID).
-
CLINICAL_TRIALS study record update · 2013-03-20A Multicenter Study of Efficacy, Safety, Tolerability, and Pharmacokinetics of Immune Globulin Subcutaneous (Human) IgPro20 in Subjects With Primary Immunodeficiency
-
CLINICAL_TRIALS study record update · 2013-01-25A Phase III Open-Label, Prospective, Multicenter Study of the Efficacy, Tolerability, Safety, and Pharmacokinetics of Immune Globulin Subcutaneous (Human), IgPro20 in Subjects With Primary Immunodeficiency (PID)
-
CLINICAL_TRIALS study record update · 2013-01-25A Multicenter Extension Study of the Efficacy, Tolerability, and Safety of Immune Globulin Subcutaneous (Human) IgPro20 in Subjects With Primary Immunodeficiency (PID)